Persistent HIV-1 replication maintains the tissue reservoir during therapy

Nature

Volumn 530, Issue 7588, 2016, Pages 51-56

  Lorenzo Redondo, Ramon ^a   Fryer, Helen R ^b   Bedford, Trevor ^c   Kim, Eun Young ^a   Archer, John ^d   Kosakovsky Pond, Sergei L ^e,l   Chung, Yoon Seok ^f   Penugonda, Sudhir ^a   Chipman, Jeffrey G ^g   Fletcher, Courtney V ^h   Schacker, Timothy W ⁱ   Malim, Michael H ^j   Rambaut, Andrew ^k   Haase, Ashley T ⁱ   McLean, Angela R ^b   Wolinsky, Steven M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Fred Hutchinson Cancer Research Center   (United States)

^d CENTRO DE INVESTIGAÇÃO EM BIODIVERSIDADE E RECURSOS GENÉTICOS   (Portugal)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j GUY S HOSPITAL   (United Kingdom)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l TEMPLE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS AND CELL COMPONENTS; CYTOGENETICS; DISEASE TREATMENT; DRUG; DRUG DEVELOPMENT; DRUG RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS; RNA; VIRAL DISEASE;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS REPLICATION; VIRUS RESISTANCE; ANTIVIRAL RESISTANCE; BIOLOGICAL MODEL; BLOOD; DNA SEQUENCE; DRUG EFFECT; GENETIC SELECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LYMPH NODE; MOLECULAR GENETICS; SPATIOTEMPORAL ANALYSIS; TIME FACTOR; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; CARRIER STATE; DRUG RESISTANCE, VIRAL; HAPLOTYPES; HIV INFECTIONS; HIV-1; HUMANS; LYMPH NODES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHYLOGENY; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; SPATIO-TEMPORAL ANALYSIS; TIME FACTORS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84957558724     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature16933     Document Type: Article

References (50)

1. Perelson, A. S. et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191 (1997).
2. Chun, T. W. et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188 (1997).
3. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Med. 5, 512-517 (1999).
4. Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300 (1997).
5. Wong, J. K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291-1295 (1997).
6. Brenchley, J. M. et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J. Virol. 78, 1160-1168 (2004).
7. Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nature Med. 15, 893-900 (2009).
8. + monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76, 707-716 (2002).
9. Persaud, D. et al. Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. J. Virol. 78, 968-979 (2004).
10. Shen, L. & Siliciano, R. F. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J. Allergy Clin. Immunol. 122, 22-28 (2008).
11. + T lymphocytes in infected children. J. Clin. Invest. 105, 995-1003 (2000).
12. Yukl, S. A. et al. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J. Infect. Dis. 208, 1212-1220 (2013).
13. Fletcher, C. V. et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl Acad. Sci. USA 111, 2307-2312 (2014).
14. Günthard, H. F. et al. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J. Virol. 73, 9404-9412 (1999).
15. Kearney, M. F. et al. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy. PLoS Pathog. 10, e1004010 (2014).
16. + T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc. Natl Acad. Sci. USA 108, 11199-11204 (2011).
17. Wong, J. K. et al. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J. Virol. 71, 2059-2071 (1997).
18. von Andrian, U. H. & Mempel, T. R. Homing and cellular traffic in lymph nodes. Nature Rev. Immunol. 3, 867-878 (2003).
19. Archer, J. et al. Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II. BMC Bioinformatics 13, 47 (2012).
20. Kim, E. Y. et al. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog. 10, e1004281 (2014).
21. Lemey, P., Rambaut, A. & Pybus, O. G. HIV evolutionary dynamics within and among hosts. AIDS Rev. 8, 125-140 (2006).
22. Frenkel, L. M. et al. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. J. Virol. 77, 5721-5730 (2003).
23. Nickle, D. C. et al. Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J. Virol. 77, 5540-5546 (2003).
24. Murrell, B. et al. Gene-wide identification of episodic selection. Mol. Biol. Evol. (2015).
25. Kryazhimskiy, S. & Plotkin, J. B. The population genetics of dN/dS. PLoS Genet. 4, e1000304 (2008).
26. Mugal, C. F., Wolf, J. B. & Kaj, I. Why time matters: codon evolution and the temporal dynamics of dN/dS. Mol. Biol. Evol. 31, 212-231 (2014).
27. Bouckaert, R. et al. BEAST 2: a software platform for Bayesian evolutionary analysis. PLOS Comput. Biol. 10, e1003537 (2014).
28. Lemey, P., Rambaut, A., Drummond, A. J. & Suchard, M. A. Bayesian phylogeography finds its roots. PLOS Comput. Biol. 5, e1000520 (2009).
29. Vaughan, T. G., Kuhnert, D., Popinga, A., Welch, D. & Drummond, A. J. Efficient Bayesian inference under the structured coalescent. Bioinformatics 30, 2272-2279 (2014).
30. Frost, S. D. W. et al. Eight challenges in phylodynamic inference. Epidemics 10, 88-92 (2015).
31. Tobin, N. H. et al. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J. Virol. 79, 9625-9634 (2005).
32. + T cells. J. Virol. 85, 5220-5223 (2011).
33. Maldarelli, F. et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345, 179-183 (2014).
34. Wagner, T. A. et al. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science (2014).
35. Althaus, C. L., Joos, B., Perelson, A. S. & Günthard, H. F. Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells. PLOS Comput. Biol. 10, e1003871 (2014).
36. Kepler, T. B. & Perelson, A. S. Drug concentration heterogeneity facilitates the evolution of drug resistance. Proc. Natl Acad. Sci. USA 95, 11514-11519 (1998).
37. Rong, L., Dahari, H., Ribeiro, R. M. & Perelson, A. S. Rapid emergence of protease inhibitor resistance in hepatitis C virus. Sci. Transl. Med. 2, 30ra32 (2010).
38. McLean, A. R. & Nowak, M. A. Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV. AIDS 6, 71-79 (1992).
39. Furtado, M. R. et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340, 1614-1622 (1999).
40. Prosperi, M. C. & Salemi, M. QuRe: software for viral quasispecies reconstruction from next-generation sequencing data. Bioinformatics 28, 132-133 (2012).
41. Pond, S. L., Frost, S. D. & Muse, S. V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21, 676-679 (2005).
42. Kosakovsky Pond, S. L., Posada, D., Gravenor, M. B., Woelk, C. H. & Frost, S. D. Automated phylogenetic detection of recombination using a genetic algorithm. Mol. Biol. Evol. 23, 1891-1901 (2006).
43. Guindon, S. & Gascuel, O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52, 696-704 (2003).
44. Anisimova, M. & Gascuel, O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 55, 539-552 (2006).
45. Hudson, R. R., Slatkin, M. & Maddison, W. P. Estimation of levels of gene flow from DNA sequence data. Genetics 132, 583-589 (1992).
46. Hudson, R. R. A new statistic for detecting genetic differentiation. Genetics 155, 2011-2014 (2000).
47. Kosakovsky Pond, S. L. et al. A random effects branch-site model for detecting episodic diversifying selection. Mol. Biol. Evol. 28, 3033-3043 (2011).
48. Kosakovsky Pond, S. L. et al. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLOS Comput. Biol. 2, e62 (2006).
49. Pybus, O. G. et al. Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution. Mol. Biol. Evol. 24, 845-852 (2007).
50. Hasegawa, M., Kishino, H. & Yano, T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 22, 160-174 (1985).